Assyro AI

FDA Orange Book · active-ingredient family

Flurbiprofen sodium

Flurbiprofen sodium is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:OCUFEN · NDA 019404

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution/drops

ProductApplicantApplicationTEApproved
OCUFENRLDALLERGANNDA 019404Dec 31, 1986

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
FLURBIPROFEN SODIUMBAUSCH AND LOMBANDA 074447Jan 04, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Flurbiprofen sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.